Australian Healthcare Associates is undertaking a project to review the existing supply and remuneration arrangements relating to programs delivered through community pharmacies under Section 100 of the National Health Act 1953, including how these arrangements impact on community pharmacy. The review is funded by the Australian Government and forms part of the Fourth Community Pharmacy Agreement, being implemented by the Agreement Consultative Committee (ACC). The ACC comprises four members from each of the Pharmacy Guild of Australia and the Department of Health and Ageing.
The objectives of the project are to:
- Review the existing supply and remuneration arrangements for drugs listed under Section 100 of the National Health Act 1953 programs and provided through community pharmacies
- Assess the effectiveness and efficiency of the current arrangements as they relate to community pharmacy
- Identify the impact of the supply and remuneration arrangements on community pharmacy and
- Develop options to address any identified impact of the current supply and remuneration arrangements on community pharmacy.
The review includes the following programs:
- Highly Specialised Drugs (HSD) Program
- Aboriginal Health Services Remote Access (AHSRA) Program
- Opiate Dependence Treatment (ODT) Program
- Special Authority (SA) Program and
- Continuing Medication (CM) Program.
A Stakeholder Information Kit has been developed to provide stakeholders with information regarding the review of supply and remuneration arrangements for drugs provided under certain Section 100 programs and delivered through community pharmacies. This document is available to download
here.
To provide comments or feedback regarding any of the five Section 100 programs being reviewed, please email your views to
S100review@ahaconsulting.com.au
Further information regarding this project is available at
Our Projects - Section 100 Drug Review